compostos inibidores de nucleosídeo fosforilase e nucleosidases, suas composições e seus usos

compostos inibidores de nucleosídeo fosforilase e nucleosidases, suas composições e seus usos. a presente invenção se refere a compostos de formula geral (i) os quais são inibidores de nucleosídeo fosforilase de purina (pnp), fosforibosiltransferase de purina (pprt), fosforilase de 5'-metiltioa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dirk Henning Lenz, Olga Vladmirovna Zubkova, Peter Charles Tyler, Richard Hubert Furneaux, Vern L. Schramm, Gary Brian Evans
Format: Patent
Sprache:por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Dirk Henning Lenz
Olga Vladmirovna Zubkova
Peter Charles Tyler
Richard Hubert Furneaux
Vern L. Schramm
Gary Brian Evans
description compostos inibidores de nucleosídeo fosforilase e nucleosidases, suas composições e seus usos. a presente invenção se refere a compostos de formula geral (i) os quais são inibidores de nucleosídeo fosforilase de purina (pnp), fosforibosiltransferase de purina (pprt), fosforilase de 5'-metiltioadenosina (mtap), nucleosidade de 5'-metiltioadenosina (mtan) e/ou hidrolase de nucleosídeo (nh) . a invenção também se refere ao uso destes compostos no tratamento de doenças e infecções incluindo câncer, infecções bacterianas, infecções por protozoários e doença mediada da célula-t e composições farmacêuticas contendo estes compostos. The present invention relates to compounds of the general formula (I) which are inhibitors of purine muclioside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5′-methylthioadenosine phosphorylases (MTAP), 5′-methylthioadenosine mucliosidases (MTAN) and/or nucleoside hydrolases (NH). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BRPI0313664B8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BRPI0313664B8</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BRPI0313664B83</originalsourceid><addsrcrecordid>eNqNjDEKwkAURLexEPUOH2sFJRJSRxTtROzjmv0LH9b8JZM9k5WlJ8jFDCjWVsPw5s3YXGu9R0WnIGnkJk5bBjmmJtWBFf3TsZJXeG0lWDD9kLihYkFIFvS5kf7RvwafCZxACYqpGXkbwLNvTsx8v7tsD0uOWjGirbnhrirPp-MqW2d5vimL7K_RG8QtQPk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>compostos inibidores de nucleosídeo fosforilase e nucleosidases, suas composições e seus usos</title><source>esp@cenet</source><creator>Dirk Henning Lenz ; Olga Vladmirovna Zubkova ; Peter Charles Tyler ; Richard Hubert Furneaux ; Vern L. Schramm ; Gary Brian Evans</creator><creatorcontrib>Dirk Henning Lenz ; Olga Vladmirovna Zubkova ; Peter Charles Tyler ; Richard Hubert Furneaux ; Vern L. Schramm ; Gary Brian Evans</creatorcontrib><description>compostos inibidores de nucleosídeo fosforilase e nucleosidases, suas composições e seus usos. a presente invenção se refere a compostos de formula geral (i) os quais são inibidores de nucleosídeo fosforilase de purina (pnp), fosforibosiltransferase de purina (pprt), fosforilase de 5'-metiltioadenosina (mtap), nucleosidade de 5'-metiltioadenosina (mtan) e/ou hidrolase de nucleosídeo (nh) . a invenção também se refere ao uso destes compostos no tratamento de doenças e infecções incluindo câncer, infecções bacterianas, infecções por protozoários e doença mediada da célula-t e composições farmacêuticas contendo estes compostos. The present invention relates to compounds of the general formula (I) which are inhibitors of purine muclioside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5′-methylthioadenosine phosphorylases (MTAP), 5′-methylthioadenosine mucliosidases (MTAN) and/or nucleoside hydrolases (NH). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.</description><language>por</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210525&amp;DB=EPODOC&amp;CC=BR&amp;NR=PI0313664B8$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210525&amp;DB=EPODOC&amp;CC=BR&amp;NR=PI0313664B8$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Dirk Henning Lenz</creatorcontrib><creatorcontrib>Olga Vladmirovna Zubkova</creatorcontrib><creatorcontrib>Peter Charles Tyler</creatorcontrib><creatorcontrib>Richard Hubert Furneaux</creatorcontrib><creatorcontrib>Vern L. Schramm</creatorcontrib><creatorcontrib>Gary Brian Evans</creatorcontrib><title>compostos inibidores de nucleosídeo fosforilase e nucleosidases, suas composições e seus usos</title><description>compostos inibidores de nucleosídeo fosforilase e nucleosidases, suas composições e seus usos. a presente invenção se refere a compostos de formula geral (i) os quais são inibidores de nucleosídeo fosforilase de purina (pnp), fosforibosiltransferase de purina (pprt), fosforilase de 5'-metiltioadenosina (mtap), nucleosidade de 5'-metiltioadenosina (mtan) e/ou hidrolase de nucleosídeo (nh) . a invenção também se refere ao uso destes compostos no tratamento de doenças e infecções incluindo câncer, infecções bacterianas, infecções por protozoários e doença mediada da célula-t e composições farmacêuticas contendo estes compostos. The present invention relates to compounds of the general formula (I) which are inhibitors of purine muclioside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5′-methylthioadenosine phosphorylases (MTAP), 5′-methylthioadenosine mucliosidases (MTAN) and/or nucleoside hydrolases (NH). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDEKwkAURLexEPUOH2sFJRJSRxTtROzjmv0LH9b8JZM9k5WlJ8jFDCjWVsPw5s3YXGu9R0WnIGnkJk5bBjmmJtWBFf3TsZJXeG0lWDD9kLihYkFIFvS5kf7RvwafCZxACYqpGXkbwLNvTsx8v7tsD0uOWjGirbnhrirPp-MqW2d5vimL7K_RG8QtQPk</recordid><startdate>20210525</startdate><enddate>20210525</enddate><creator>Dirk Henning Lenz</creator><creator>Olga Vladmirovna Zubkova</creator><creator>Peter Charles Tyler</creator><creator>Richard Hubert Furneaux</creator><creator>Vern L. Schramm</creator><creator>Gary Brian Evans</creator><scope>EVB</scope></search><sort><creationdate>20210525</creationdate><title>compostos inibidores de nucleosídeo fosforilase e nucleosidases, suas composições e seus usos</title><author>Dirk Henning Lenz ; Olga Vladmirovna Zubkova ; Peter Charles Tyler ; Richard Hubert Furneaux ; Vern L. Schramm ; Gary Brian Evans</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BRPI0313664B83</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>Dirk Henning Lenz</creatorcontrib><creatorcontrib>Olga Vladmirovna Zubkova</creatorcontrib><creatorcontrib>Peter Charles Tyler</creatorcontrib><creatorcontrib>Richard Hubert Furneaux</creatorcontrib><creatorcontrib>Vern L. Schramm</creatorcontrib><creatorcontrib>Gary Brian Evans</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Dirk Henning Lenz</au><au>Olga Vladmirovna Zubkova</au><au>Peter Charles Tyler</au><au>Richard Hubert Furneaux</au><au>Vern L. Schramm</au><au>Gary Brian Evans</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>compostos inibidores de nucleosídeo fosforilase e nucleosidases, suas composições e seus usos</title><date>2021-05-25</date><risdate>2021</risdate><abstract>compostos inibidores de nucleosídeo fosforilase e nucleosidases, suas composições e seus usos. a presente invenção se refere a compostos de formula geral (i) os quais são inibidores de nucleosídeo fosforilase de purina (pnp), fosforibosiltransferase de purina (pprt), fosforilase de 5'-metiltioadenosina (mtap), nucleosidade de 5'-metiltioadenosina (mtan) e/ou hidrolase de nucleosídeo (nh) . a invenção também se refere ao uso destes compostos no tratamento de doenças e infecções incluindo câncer, infecções bacterianas, infecções por protozoários e doença mediada da célula-t e composições farmacêuticas contendo estes compostos. The present invention relates to compounds of the general formula (I) which are inhibitors of purine muclioside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5′-methylthioadenosine phosphorylases (MTAP), 5′-methylthioadenosine mucliosidases (MTAN) and/or nucleoside hydrolases (NH). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language por
recordid cdi_epo_espacenet_BRPI0313664B8
source esp@cenet
subjects CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
title compostos inibidores de nucleosídeo fosforilase e nucleosidases, suas composições e seus usos
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T07%3A29%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Dirk%20Henning%20Lenz&rft.date=2021-05-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBRPI0313664B8%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true